Eli Lilly (LLY)

• Market cap: $836B
• 1 day: -1.98%
• 5 days: 4.42%
• 1 month: -8.09%
• 3 months: -13.4%
• 6 months: 14.12%
• Year to date: -13.4%
• 1 year: 14.34%
• 5 years: 406.02%
• 10 years: 1,178.46%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Employees: 50,000